Connor, Clark & Lunn Investment Management (CC&L)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-13,906
| Closed | -$85K | – | 1196 |
|
|
2020
Q2 | $85K | Sell |
13,906
-4,209
| -23% | -$25.7K | ﹤0.01% | 963 |
|
|
2020
Q1 | $41K | Sell |
18,115
-2,425
| -12% | -$5.49K | ﹤0.01% | 972 |
|
|
2019
Q4 | $94K | Buy |
+20,540
| New | +$94K | ﹤0.01% | 881 |
|
|
2018
Q3 | – | Sell |
-24,625
| Closed | -$389K | – | 1151 |
|
|
2018
Q2 | $389K | Sell |
24,625
-5,750
| -19% | -$90.8K | ﹤0.01% | 823 |
|
|
2018
Q1 | $522K | Buy |
+30,375
| New | +$522K | ﹤0.01% | 562 |
|
|
2017
Q1 | – | Sell |
-11,600
| Closed | -$581K | – | 1046 |
|
|
2016
Q4 | $581K | Sell |
11,600
-20,750
| -64% | -$1.04M | ﹤0.01% | 572 |
|
|
2016
Q3 | $1.7M | Sell |
32,350
-575
| -2% | -$30.2K | 0.01% | 392 |
|
|
2016
Q2 | $1.36M | Buy |
+32,925
| New | +$1.36M | 0.01% | 421 |
|